This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Healthy
Interventions
DRUG

Placebo

Tablet

DRUG

BI 1358894

Tablet

DRUG

BI 1358894 (Test)

Fasting state

DRUG

BI 1358894 (Reference)

Fed state

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY